Intrathecal baclofen therapy may reduce severe spasticity. The programmable pump delivers medication to where it’s needed – the spinal cord. This treatment option is adaptable, if necessary reversible, and non-destructive.
For spasticity of spinal origin, chronic infusion of baclofen via a drug delivery pump should be reserved for patients unresponsive to oral baclofen or those who experience intolerable side effects at effective doses.
Intrathecal baclofen therapy (ITB) therapy is a precise, targeted treatment that may reduce severe spasticity caused by multiple sclerosis.
All treatment and outcome results are specific to the individual patient, and will form part of your consultation with your healthcare professional.
Please consult your healthcare professional for a full list of benefits, indications, precautions, clinical results, and other important medical information that pertains to ITB therapy.
Review some common questions and concerns about how a baclofen pump (ITB therapy) may help minimise severe spasticity caused by multiple sclerosis.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.